NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization0.1293 mln
Float0.88 mln
Earnings Date05/30/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
0.54
Moderate leverage
ROE
-717
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Aditxt Inc. is a California-based company focused on developing tools and treatments that help people better understand and manage their immune systems. Its core offerings include a personal immune health monitoring system and a therapy designed to teach the body to tolerate its own tissues, reducing harmful immune responses. The company is also advancing treatments for conditions such as psoriasis, type 1 diabetes, and multiple sclerosis, supported by licensing agreements with two leading research universities.
